IL34 and periodontal disorder: Increased IL-34 RNA and protein expression was documented in various diseases, including autoimmune and inflammatory disorders, infections, metabolic diseases, neurological disorders, and fibrosis while a reduced expression of the cytokine was documented in Alzheimer’s disease, atopic dermatitis, hepatitis B viral infection, and periodontal diseases [23, 26, 28–38] (Table 1).